Insider Transactions in Q2 2023 at Phreesia, Inc. (PHR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
201
+0.16%
|
$5,226
$26.21 P/Share
|
|
Jun 30
2023
|
Janet Gunzburg Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
148
+0.37%
|
$3,848
$26.21 P/Share
|
|
Jun 28
2023
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,051
+19.26%
|
-
|
|
Jun 28
2023
|
Ramin Sayar Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,051
+24.91%
|
-
|
|
Jun 28
2023
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,051
+21.45%
|
-
|
|
Jun 28
2023
|
Michael Weintraub Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,051
+3.24%
|
-
|
|
Jun 28
2023
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,051
+12.05%
|
-
|
|
Jun 28
2023
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,051
+16.9%
|
-
|
|
Jun 17
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
27
-0.34%
|
$837
$31.79 P/Share
|
|
Jun 17
2023
|
Janet Gunzburg Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-0.29%
|
$3,627
$31.79 P/Share
|
|
Jun 16
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
67
-0.85%
|
$2,077
$31.79 P/Share
|
|
Jun 15
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
40
-0.5%
|
$1,320
$33.44 P/Share
|
|
May 10
2023
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
3,555
-15.54%
|
$106,650
$30.06 P/Share
|
|
May 09
2023
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,453
+0.99%
|
$99,624
$8.03 P/Share
|
|
May 01
2023
|
Janet Gunzburg Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-0.67%
|
$8,401
$31.64 P/Share
|
|
Apr 28
2023
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
316
+0.82%
|
$9,796
$31.64 P/Share
|
|
Apr 28
2023
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
316
+1.36%
|
$9,796
$31.64 P/Share
|
|
Apr 28
2023
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
316
+1.32%
|
$9,796
$31.64 P/Share
|
|
Apr 21
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,075
-1.11%
|
$35,475
$33.13 P/Share
|
|
Apr 18
2023
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,452
-1.03%
|
$238,464
$32.09 P/Share
|
|
Apr 17
2023
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,600
-0.36%
|
$83,200
$32.01 P/Share
|
|
Apr 17
2023
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,113
-2.41%
|
$65,503
$31.83 P/Share
|
|
Apr 17
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
570
-0.48%
|
$17,670
$31.84 P/Share
|
|
Apr 17
2023
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
21,387
+15.13%
|
$0
$0.84 P/Share
|
|
Apr 16
2023
|
Janet Gunzburg Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,481
+19.1%
|
$293,911
$31.64 P/Share
|
|
Apr 16
2023
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Indirect |
2,212
+21.78%
|
$68,572
$31.64 P/Share
|
|
Apr 14
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
3,306
-2.51%
|
$102,486
$31.16 P/Share
|
|
Apr 14
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,172
-0.88%
|
$36,332
$31.64 P/Share
|
|
Apr 14
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,781
-0.24%
|
$55,211
$31.64 P/Share
|
|
Apr 14
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
1,123
-1.15%
|
$34,813
$31.64 P/Share
|
|
Apr 14
2023
|
Balaji Gandhi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
807
-0.91%
|
$25,017
$31.64 P/Share
|
|
Apr 14
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,089
-0.25%
|
$95,759
$31.64 P/Share
|
|
Apr 14
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
623
-0.63%
|
$19,313
$31.64 P/Share
|
|
Apr 14
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,948
-0.94%
|
$60,388
$31.64 P/Share
|
|
Apr 12
2023
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.03%
|
$6,400
$32.01 P/Share
|
|
Apr 11
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
3,466
-3.42%
|
$103,980
$30.91 P/Share
|
|
Apr 10
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,775
-2.76%
|
$113,250
$30.15 P/Share
|
|
Apr 10
2023
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,081
+4.93%
|
-
|
|
Apr 10
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
2,196
-2.16%
|
$65,880
$30.15 P/Share
|
|
Apr 10
2023
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
4,956
+4.66%
|
-
|
|
Apr 10
2023
|
Balaji Gandhi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,843
-3.11%
|
$85,290
$30.15 P/Share
|
|
Apr 10
2023
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,956
+5.14%
|
-
|
|
Apr 10
2023
|
Janet Gunzburg Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,123
-2.66%
|
$33,690
$30.15 P/Share
|
|
Apr 10
2023
|
Janet Gunzburg Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,115
+6.86%
|
-
|
|
Apr 10
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,885
-0.64%
|
$236,550
$30.15 P/Share
|
|
Apr 10
2023
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,587
+1.17%
|
-
|
|
Apr 10
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,529
-0.62%
|
$135,870
$30.15 P/Share
|
|
Apr 10
2023
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,497
+1.15%
|
-
|
|
Apr 10
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
3,615
-3.44%
|
$108,450
$30.15 P/Share
|
|
Apr 10
2023
|
Michael J. Davidoff SVP, Payer Business |
BUY
Grant, award, or other acquisition
|
Direct |
7,081
+6.31%
|
-
|